MEDIFAST INC (MED)vsRollins Inc (ROL)
MED
MEDIFAST INC
$9.61
+0.21%
CONSUMER CYCLICAL · Cap: $109.91M
ROL
Rollins Inc
$53.48
+0.36%
CONSUMER CYCLICAL · Cap: $25.78B
Smart Verdict
WallStSmart Research — data-driven comparison
Rollins Inc generates 875% more annual revenue ($3.76B vs $385.79M). ROL leads profitability with a 14.0% profit margin vs -4.8%. MED appears more attractively valued with a PEG of 0.97. ROL earns a higher WallStSmart Score of 52/100 (C-).
MED
Hold45
out of 100
Grade: D
ROL
Buy52
out of 100
Grade: C-
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Intrinsic value data unavailable for MED.
Margin of Safety
-165.8%
Fair Value
$24.68
Current Price
$53.48
$28.80 premium
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Reasonable price relative to book value
Safe zone — low bankruptcy risk
Growing faster than its price suggests
Every $100 of equity generates 39 in profit
Areas to Watch
Smaller company, higher risk/reward
Weak financial health signals
ROE of -9.1% — below average capital efficiency
Revenue declined 36.9%
Trading at 18.7x book value
Weak financial health signals
Expensive relative to growth rate
Premium valuation, high expectations priced in
Comparative Analysis Report
WallStSmart ResearchBull Case : MED
The strongest argument for MED centers on Price/Book, Altman Z-Score, PEG Ratio. PEG of 0.97 suggests the stock is reasonably priced for its growth.
Bull Case : ROL
The strongest argument for ROL centers on Return on Equity.
Bear Case : MED
The primary concerns for MED are Market Cap, Piotroski F-Score, Return on Equity.
Bear Case : ROL
The primary concerns for ROL are Price/Book, Piotroski F-Score, PEG Ratio. A P/E of 49.1x leaves little room for execution misses.
Key Dynamics to Monitor
MED profiles as a turnaround stock while ROL is a value play — different risk/reward profiles.
ROL carries more volatility with a beta of 0.80 — expect wider price swings.
ROL is growing revenue faster at 9.7% — sustainability is the question.
ROL generates stronger free cash flow (159M), providing more financial flexibility.
Bottom Line
ROL scores higher overall (52/100 vs 45/100). Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
MEDIFAST INC
CONSUMER CYCLICAL · PERSONAL SERVICES · USA
Medifast, Inc. manufactures and distributes weight loss, weight management, healthy living products, and other consumable health and nutrition products in the United States and Asia-Pacific. The company is headquartered in Baltimore, Maryland.
Visit Website →Rollins Inc
CONSUMER CYCLICAL · PERSONAL SERVICES · USA
Rollins, Inc. is a North American consumer and commercial services company.
Visit Website →Compare with Other PERSONAL SERVICES Stocks
Want to dig deeper into these stocks?